Zebrafish neurobehavioral phenomics for aquatic neuropharmacology and toxicology research.

Zebrafish (Danio rerio) are rapidly emerging as an important model organism for aquatic neuropharmacology and toxicology research. The behavioral/phenotypic complexity of zebrafish allows for thorough dissection of complex human brain disorders and drug-evoked pathological states. As numerous zebrafish models become available with a wide spectrum of behavioral, genetic, and environmental methods to test novel drugs, here we discuss recent zebrafish phenomics methods to facilitate drug discovery, particularly in the field of biological psychiatry. Additionally, behavioral, neurological, and endocrine endpoints are becoming increasingly well-characterized in zebrafish, making them an inexpensive, robust and effective model for toxicology research and pharmacological screening. We also discuss zebrafish behavioral phenotypes, experimental considerations, pharmacological candidates and relevance of zebrafish neurophenomics to other 'omics' (e.g., genomic, proteomic) approaches. Finally, we critically evaluate the limitations of utilizing this model organism, and outline future strategies of research in the field of zebrafish phenomics.

[1]  Robert Weibel,et al.  Integrating cross-scale analysis in the spatial and temporal domains for classification of behavioral movement , 2014, J. Spatial Inf. Sci..

[2]  V. Höllt,et al.  Acute injection of drugs with low addictive potential (delta(9)-tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine). , 1999, Brain research. Molecular brain research.

[3]  Siddharth Gaikwad,et al.  Automated high-throughput neurophenotyping of zebrafish social behavior , 2012, Journal of Neuroscience Methods.

[4]  Valter Tucci,et al.  Cognitive Aging in Zebrafish , 2006, PloS one.

[5]  D. Luckenbaugh,et al.  Family History of Alcohol Dependence and Initial Antidepressant Response to an N-methyl-D-aspartate Antagonist , 2009, Biological Psychiatry.

[6]  C. Dlugos,et al.  Effects of chronic ethanol administration on brain protein levels: a proteomic investigation using 2-D DIGE system. , 2006, European journal of pharmacology.

[7]  F. Sharp,et al.  Effects of phencyclidine on immediate early gene expression in the brain , 1996, Journal of neuroscience research.

[8]  C. Maximino,et al.  Pharmacological analysis of zebrafish (Danio rerio) scototaxis , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  Mark J. Thomas,et al.  Nicotine response genetics in the zebrafish , 2009, Proceedings of the National Academy of Sciences.

[10]  A. Arukwe,et al.  Modulation of steroidogenesis and xenobiotic biotransformation responses in zebrafish (Danio rerio) exposed to water-soluble fraction of crude oil. , 2008, Environmental research.

[11]  Matthew O. Parker,et al.  Housing Conditions Differentially Affect Physiological and Behavioural Stress Responses of Zebrafish, as well as the Response to Anxiolytics , 2012, PloS one.

[12]  B. Roth,et al.  Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor. , 2003, Trends in pharmacological sciences.

[13]  M. Tysklind,et al.  Bioaccumulation of Selected PCBs in Zebrafish, Three-Spined Stickleback, and Arctic Char After Three Different Routes of Exposure , 2001, Archives of environmental contamination and toxicology.

[14]  Michael Bader,et al.  Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform , 2003, Science.

[15]  Holly A Swain,et al.  Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio). , 2004, Neurotoxicology and teratology.

[16]  H. Baier,et al.  An affective disorder in zebrafish with mutation of the glucocorticoid receptor , 2012, Molecular Psychiatry.

[17]  M. Faraday,et al.  Effects of chronic nicotine administration on locomotion depend on rat sex and housing condition. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[18]  Matthew O. Parker,et al.  Behavioural phenotyping of casper mutant and 1-pheny-2-thiourea treated adult zebrafish. , 2013, Zebrafish.

[19]  Allan V. Kalueff,et al.  Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish , 2009, Behavioural Brain Research.

[20]  A. Stewart,et al.  Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds. , 2013, ACS chemical neuroscience.

[21]  R. Gerlai,et al.  Acute ethanol exposure induces behavioural differences in two zebrafish (Danio rerio) strains: A time course analysis , 2014, Behavioural Brain Research.

[22]  R. Strassman,et al.  Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study , 2015, Journal of psychopharmacology.

[23]  S. Ekker,et al.  Zebrafish: a model for the study of addiction genetics , 2011, Human Genetics.

[24]  Laure Bally-Cuif,et al.  Adult zebrafish as a model organism for behavioural genetics , 2010, BMC Neuroscience.

[25]  M. Vijayan,et al.  Development of the corticosteroid stress axis and receptor expression in zebrafish. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[26]  P. Vernier,et al.  Emotions and motivated behavior converge on an amygdala-like structure in the zebrafish , 2014, The European journal of neuroscience.

[27]  Z. Cai,et al.  Effects of chronic tramadol exposure on the zebrafish brain: a proteomic study. , 2012, Journal of proteomics.

[28]  Felipe Fregni,et al.  A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. , 2008, The international journal of neuropsychopharmacology.

[29]  D. Nutt,et al.  Experienced Drug Users Assess the Relative Harms and Benefits of Drugs: A Web-Based Survey , 2013, Journal of psychoactive drugs.

[30]  Daniel Schlenk,et al.  Analysis of Endocrine Disruption in Southern California Coastal Fish Using an Aquatic Multispecies Microarray , 2008, Environmental health perspectives.

[31]  S. Spagnoli,et al.  Pseudoloma neurophilia: a retrospective and descriptive study of nervous system and muscle infections, with new implications for pathogenesis and behavioral phenotypes. , 2015, Zebrafish.

[32]  G. Heinrich,et al.  Brain-derived neurotrophic factor gene organization and transcription in the zebrafish embryo , 2001, International Journal of Developmental Neuroscience.

[33]  D. E. Nichols,et al.  Effects of Schedule I drug laws on neuroscience research and treatment innovation , 2013, Nature Reviews Neuroscience.

[34]  Evan J. Kyzar,et al.  Zebrafish models to study drug abuse-related phenotypes , 2011, Reviews in the neurosciences.

[35]  R. Strassman,et al.  Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up. , 2002, Journal of substance abuse treatment.

[36]  D. Charney,et al.  Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression , 2010, Biological Psychiatry.

[37]  M. Sundvik,et al.  The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases , 2010, Neurobiology of Disease.

[38]  J. González-Maeso,et al.  Animal models of serotonergic psychedelics. , 2013, ACS chemical neuroscience.

[39]  J. Zohar,et al.  Immediate ketamine treatment does not prevent posttraumatic stress responses in an animal model for PTSD , 2014, European Neuropsychopharmacology.

[40]  Wei Cheng,et al.  Myotonia Congenita-Associated Mutations in Chloride Channel-1 Affect Zebrafish Body Wave Swimming Kinematics , 2014, PloS one.

[41]  V. Sukhatme,et al.  The zebrafish egr1 gene encodes a highly conserved, zinc-finger transcriptional regulator. , 1994, DNA and cell biology.

[42]  H. Yoshioka,et al.  Characterization and expression of serotonin transporter genes in zebrafish. , 2006, The Tohoku journal of experimental medicine.

[43]  Michael Nguyen,et al.  A novel 3D method of locomotor analysis in adult zebrafish: Implications for automated detection of CNS drug-evoked phenotypes , 2015, Journal of Neuroscience Methods.

[44]  Ngoc Kim Nhung Nguyen,et al.  Zebrafish Behavior in Novel Environments: Effects of Acute Exposure to Anxiolytic Compounds and Choice of Danio rerio Line. , 2010, International journal of comparative psychology.

[45]  Demetrio Raldúa,et al.  Clofibrate and gemfibrozil induce an embryonic malabsorption syndrome in zebrafish. , 2008, Toxicology and applied pharmacology.

[46]  Jan Kaslin,et al.  Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (Danio rerio) , 2001, The Journal of comparative neurology.

[47]  R. Nourizadeh-Lillabadi,et al.  Differential gene expression and biomarkers in zebrafish (Danio rerio) following exposure to produced water components. , 2008, Aquatic toxicology.

[48]  B. Slack,et al.  Zebrafish as a Genetic Model in Biological and Behavioral Gerontology: Where Development Meets Aging in Vertebrates – A Mini-Review , 2009, Gerontology.

[49]  T. Brewerton,et al.  Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study , 2013, Journal of psychopharmacology.

[50]  D. Braida,et al.  Hallucinatory and rewarding effect of salvinorin A in zebrafish: κ-opioid and CB1-cannabinoid receptor involvement , 2007, Psychopharmacology.

[51]  Su Guo,et al.  Identification of a brain center whose activity discriminates a choice behavior in zebrafish , 2011, Proceedings of the National Academy of Sciences.

[52]  A. Stewart,et al.  Skin too thin? The developing utility of zebrafish skin (neuro)pharmacology for CNS drug discovery research , 2013, Brain Research Bulletin.

[53]  Richard S. Mohn,et al.  Zebrafish and conditioned place preference: A translational model of drug reward , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[54]  J. Godwin,et al.  Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment , 2013, BMC Genomics.

[55]  A. Ennaceur,et al.  MK-801 increases the baseline level of anxiety in mice introduced to a spatial memory task without prior habituation , 2011, Neuropharmacology.

[56]  A. Stewart,et al.  Aquatic blues: Modeling depression and antidepressant action in zebrafish , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[57]  G. Torres,et al.  A behavioral and molecular analysis of ketamine in zebrafish , 2011, Synapse.

[58]  Evan J. Kyzar,et al.  Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[59]  Bryan L. Roth,et al.  Chemical Informatics and Target Identification in a Zebrafish Phenotypic Screen , 2011, Nature chemical biology.

[60]  Urban Liebel,et al.  Behavioral barcoding in the cloud: embracing data-intensive digital phenotyping in neuropharmacology. , 2012, Trends in biotechnology.

[61]  G. Cahill,et al.  Development of a circadian melatonin rhythm in embryonic zebrafish. , 1999, Brain research. Developmental brain research.

[62]  Robert Gerlai,et al.  Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery , 2015, Front. Behav. Neurosci..

[63]  T. Sotnikova,et al.  Tryptophan Hydroxylase-2 Controls Brain Serotonin Synthesis , 2004, Science.

[64]  Maia J. Benner,et al.  Zebrafish (Danio rerio) vary by strain and sex in their behavioral and transcriptional responses to selenium supplementation. , 2010, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[65]  Fair M. Vassoler,et al.  Epigenetic Inheritance of a Cocaine Resistance Phenotype , 2012, Nature Neuroscience.

[66]  T. S. Krebs,et al.  Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials , 2012, Journal of psychopharmacology.

[67]  Meiqing Jin,et al.  Developmental toxicity of bifenthrin in embryo-larval stages of zebrafish. , 2009, Aquatic toxicology.

[68]  Michael Kometer,et al.  The neurobiology of psychedelic drugs: implications for the treatment of mood disorders , 2010, Nature Reviews Neuroscience.

[69]  C. Maximino,et al.  Behavioral and neurochemical changes in the zebrafish leopard strain , 2013, Genes, brain, and behavior.

[70]  I. Zhdanova,et al.  Gender differences in zebrafish responses to cocaine withdrawal , 2008, Physiology & Behavior.

[71]  M. Calcagnotto,et al.  Differences in Spatio-Temporal Behavior of Zebrafish in the Open Tank Paradigm after a Short-Period Confinement into Dark and Bright Environments , 2011, PloS one.

[72]  John H Krystal,et al.  Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.

[73]  A. Stewart,et al.  Modeling seizure-related behavioral and endocrine phenotypes in adult zebrafish , 2010, Brain Research.

[74]  A. Stewart,et al.  Building Zebrafish Neurobehavioral Phenomics: Effects of Common Environmental Factors on Anxiety and Locomotor Activity. , 2015, Zebrafish.

[75]  A. Stewart,et al.  Perspectives on experimental models of serotonin syndrome in zebrafish , 2013, Neurochemistry International.

[76]  L. Bally-Cuif,et al.  Comparative analysis of serotonin receptor (HTR1A/HTR1B families) and transporter (slc6a4a/b) gene expression in the zebrafish brain , 2008, The Journal of comparative neurology.

[77]  D. Murphy,et al.  The developing use of heterozygous mutant mouse models in brain monoamine transporter research. , 2007, Trends in pharmacological sciences.

[78]  E. Nestler,et al.  Neurobehavioral assessment in the information age , 2004, Nature Neuroscience.

[79]  David J. Echevarria,et al.  The utility of the zebrafish model in conditioned place preference to assess the rewarding effects of drugs , 2013, Behavioural pharmacology.

[80]  Christopher J Martyniuk,et al.  Microarray analysis in the zebrafish (Danio rerio) liver and telencephalon after exposure to low concentration of 17alpha-ethinylestradiol. , 2007, Aquatic toxicology.

[81]  David J. Echevarria,et al.  A Novel Behavioral Test Battery to Assess Global Drug Effects Using the Zebrafish , 2008, International Journal of Comparative Psychology.

[82]  Siddharth Gaikwad,et al.  Behavioral and physiological effects of RDX on adult zebrafish. , 2012, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[83]  H. Baier,et al.  A zebrafish model of glucocorticoid resistance shows serotonergic modulation of the stress response , 2012, Front. Behav. Neurosci..

[84]  He-qing Huang,et al.  Proteomic analysis of methyl parathion-responsive proteins in zebrafish (Danio rerio) brain. , 2011, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[85]  R. Martienssen,et al.  Transgenerational Epigenetic Inheritance: Myths and Mechanisms , 2014, Cell.

[86]  S. Helene Richter,et al.  Environmental standardization: cure or cause of poor reproducibility in animal experiments? , 2009, Nature Methods.

[87]  C. Zarate,et al.  Antidepressant actions of ketamine: from molecular mechanisms to clinical practice , 2015, Current Opinion in Neurobiology.

[88]  Yogesh K. Dwivedi.  Brain-derived neurotrophic factor: role in depression and suicide , 2009, Neuropsychiatric disease and treatment.

[89]  E. Hirsch,et al.  c-fos protein-like immunoreactivity: Distribution in the human brain and over-expression in the hippocampus of patients with Alzheimer's disease , 1992, Neuroscience.

[90]  G. Sayler,et al.  Global gene expression in larval zebrafish (Danio rerio) exposed to selective serotonin reuptake inhibitors (fluoxetine and sertraline) reveals unique expression profiles and potential biomarkers of exposure. , 2012, Environmental pollution.

[91]  W. Foote,et al.  Lysergic Acid Diethylamide: Sensitive Neuronal Units in the Midbrain Raphe , 1968, Science.

[92]  A. Stewart,et al.  Aquatic toxicology of fluoxetine: understanding the knowns and the unknowns. , 2014, Aquatic toxicology.

[93]  Siddharth Gaikwad,et al.  Measuring behavioral and endocrine responses to novelty stress in adult zebrafish , 2010, Nature Protocols.

[94]  Chereen Collymore,et al.  The Behavioral Effects of Single Housing and Environmental Enrichment on Adult Zebrafish (Danio rerio). , 2015, Journal of the American Association for Laboratory Animal Science : JAALAS.

[95]  R. Strassman,et al.  Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans , 1996, Biological Psychiatry.

[96]  V. Sallinen,et al.  Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. , 2006, Zebrafish.

[97]  M. Picciotto,et al.  Sex differences in anxiety-like behavior and locomotor activity following chronic nicotine exposure in mice , 2008, Neuroscience Letters.

[98]  Michael R. Taylor,et al.  Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression , 2005, Neuroscience.

[99]  G. Ankley,et al.  Proteomic analysis of zebrafish brain tissue following exposure to the pesticide prochloraz. , 2011, Aquatic toxicology.

[100]  Evan J. Kyzar,et al.  Three-Dimensional Neurophenotyping of Adult Zebrafish Behavior , 2011, PloS one.

[101]  M. Idris,et al.  Proteomic and gene expression analysis of zebrafish brain undergoing continuous light/dark stress , 2015, Journal of sleep research.

[102]  Siddharth Gaikwad,et al.  Characterization of behavioral and endocrine effects of LSD on zebrafish , 2010, Behavioural Brain Research.

[103]  A. Stewart,et al.  Modeling neuropsychiatric spectra to empower translational biological psychiatry , 2015, Behavioural Brain Research.

[104]  Christina N. Toms,et al.  Alcohol-induced behavior change in zebrafish models , 2011, Reviews in the neurosciences.

[105]  Y. Nishimura,et al.  In vivo assessment of the permeability of the blood-brain barrier and blood-retinal barrier to fluorescent indoline derivatives in zebrafish , 2012, BMC Neuroscience.

[106]  Jan Kaslin,et al.  The Orexin/Hypocretin System in Zebrafish Is Connected to the Aminergic and Cholinergic Systems , 2004, The Journal of Neuroscience.

[107]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[108]  Monica Gomes Lima,et al.  Fingerprinting of Psychoactive Drugs in Zebrafish Anxiety-Like Behaviors , 2014, PloS one.

[109]  Evan J. Kyzar,et al.  Constructing the habituome for phenotype-driven zebrafish research , 2013, Behavioural Brain Research.

[110]  J. Ramsdell,et al.  DDT Exposure of Zebrafish Embryos Enhances Seizure Susceptibility: Relationship to Fetal p,p′-DDE Burden and Domoic Acid Exposure of California Sea Lions , 2008, Environmental health perspectives.

[111]  D. Nutt,et al.  Harms associated with psychoactive substances: findings of the UK National Drug Survey , 2010, Journal of psychopharmacology.

[112]  B. Robison,et al.  Strain-specific alteration of zebrafish feeding behavior in response to aversive stimuli. , 2008, Canadian journal of zoology.

[113]  Alexander Chong Shu-Chien,et al.  Mitragynine Attenuates Withdrawal Syndrome in Morphine-Withdrawn Zebrafish , 2011, PloS one.

[114]  Alan Christoffels,et al.  Fugu genome analysis provides evidence for a whole-genome duplication early during the evolution of ray-finned fishes. , 2004, Molecular biology and evolution.

[115]  S. Sealfon,et al.  Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists , 2011, Neuroscience Letters.

[116]  Robert Gerlai,et al.  Zebrafish as an emerging model for studying complex brain disorders. , 2014, Trends in pharmacological sciences.

[117]  Gang Bai,et al.  Behavioural screening of zebrafish using neuroactive traditional Chinese medicine prescriptions and biological targets , 2014, Scientific Reports.

[118]  S. Wilson,et al.  Hedgehog and Fgf signaling pathways regulate the development of tphR-expressing serotonergic raphe neurons in zebrafish embryos. , 2004, Journal of neurobiology.

[119]  M. Baker,et al.  Evolution of 11β‐hydroxysteroid dehydrogenase‐type 1 and 11β‐hydroxysteroid dehydrogenase‐type 3 , 2010, FEBS letters.

[120]  R. Gerlai.  Phenomics: fiction or the future? , 2002, Trends in Neurosciences.

[121]  Matthew O. Parker,et al.  Molecular psychiatry of zebrafish , 2014, Molecular Psychiatry.

[122]  E. Kremmer,et al.  The serotonergic phenotype is acquired by converging genetic mechanisms within the zebrafish central nervous system , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[123]  A. Stewart,et al.  Developing ‘integrative’ zebrafish models of behavioral and metabolic disorders , 2013, Behavioural Brain Research.

[124]  Elissa J Chesler,et al.  Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive , 2002, Neuroscience & Biobehavioral Reviews.

[125]  M. Idris,et al.  Proteomic profile of zebrafish brain based on two-dimensional gel electrophoresis matrix-assisted laser desorption/ionization MS/MS analysis. , 2010, Zebrafish.

[126]  Randall T Peterson,et al.  Using the zebrafish photomotor response for psychotropic drug screening. , 2011, Methods in cell biology.

[127]  Lawrence D Phillips,et al.  Drug harms in the UK: a multicriteria decision analysis , 2010, The Lancet.

[128]  R. Gerlai,et al.  Strain dependent gene expression and neurochemical levels in the brain of zebrafish: Focus on a few alcohol related targets , 2012, Physiology & Behavior.

[129]  M. Faraday,et al.  Effects of nicotine on elevated plus maze and locomotor activity in male and female adolescent and adult rats , 2004, Pharmacology Biochemistry and Behavior.

[130]  B. Gough,et al.  Drug-induced circling preference in rats , 1995, Molecular Neurobiology.

[131]  Robert Gerlai,et al.  Zebrafish models for translational neuroscience research: from tank to bedside , 2014, Trends in Neurosciences.

[132]  Christina N. Toms,et al.  Back to basics: searching for a comprehensive framework for exploring individual differences in zebrafish (Danio rerio) behavior. , 2014, Zebrafish.

[133]  Randall T Peterson,et al.  Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish. , 2008, Briefings in functional genomics & proteomics.

[134]  G. Murdoch,et al.  Is Behavioral Variation along the Bold-Shy Continuum Associated with Variation in the Stress Axis in Zebrafish?* , 2012, Physiological and Biochemical Zoology.

[135]  Yongyong Guo,et al.  Parental transfer of polybrominated diphenyl ethers (PBDEs) and thyroid endocrine disruption in zebrafish. , 2011, Environmental science & technology.

[136]  Kyu-Won Kim,et al.  Functional and developmental analysis of the blood–brain barrier in zebrafish , 2008, Brain Research Bulletin.

[137]  R. Gerlai,et al.  Recent advances with a novel model organism: Alcohol tolerance and sensitization in zebrafish (Danio rerio) , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[138]  V. Tropepe,et al.  Changes in the social environment induce neurogenic plasticity predominantly in niches residing in sensory structures of the zebrafish brain independently of cortisol levels , 2014, Developmental neurobiology.

[139]  G. Bruni,et al.  Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish , 2014, Front. Pharmacol..

[140]  Hanno Würbel,et al.  Behaviour and the standardization fallacy , 2000, Nature Genetics.

[141]  S. Haggarty,et al.  Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation , 2010, Science.

[142]  W. Foote,et al.  Action of psychotogenic drugs on single midbrain raphe neurons. , 1970, The Journal of pharmacology and experimental therapeutics.

[143]  L. Jerome,et al.  The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study , 2011, Journal of psychopharmacology.

[144]  A. Stewart,et al.  Gaining translational momentum: More zebrafish models for neuroscience research , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[145]  Stuart C. Sealfon,et al.  Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior , 2007, Neuron.

[146]  T. Ray.  Correction: Psychedelics and the Human Receptorome , 2010, PLoS ONE.

[147]  R. Blaser,et al.  Measures of Anxiety in Zebrafish (Danio rerio): Dissociation of Black/White Preference and Novel Tank Test , 2012, PloS one.

[148]  Thomas S. Ray,et al.  Psychedelics and the Human Receptorome , 2010, PloS one.

[149]  G. Giaroli,et al.  Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles , 2014, Therapeutic advances in psychopharmacology.

[150]  M. Settles,et al.  Brain transcriptome variation among behaviorally distinct strains of zebrafish (Danio rerio) , 2012, BMC Genomics.

[151]  Wolfgang Driever,et al.  Genetic dissection of dopaminergic and noradrenergic contributions to catecholaminergic tracts in early larval zebrafish , 2009, The Journal of comparative neurology.

[152]  Philippe Vernier,et al.  Two tyrosine hydroxylase genes in vertebrates New dopaminergic territories revealed in the zebrafish brain , 2010, Molecular and Cellular Neuroscience.

[153]  G. Murdoch,et al.  Effect of starvation on transcriptomes of brain and liver in adult female zebrafish (Danio rerio). , 2008, Physiological genomics.

[154]  Siddharth Gaikwad,et al.  Unique and potent effects of acute ibogaine on zebrafish: The developing utility of novel aquatic models for hallucinogenic drug research , 2013, Behavioural Brain Research.

[155]  Siddharth Gaikwad,et al.  Analyzing habituation responses to novelty in zebrafish (Danio rerio) , 2010, Behavioural Brain Research.

[156]  Evan J. Kyzar,et al.  Behavioral effects of MDMA (‘ecstasy’) on adult zebrafish , 2011, Behavioural pharmacology.

[157]  Donald M. O’Malley,et al.  Prey Tracking by Larval Zebrafish: Axial Kinematics and Visual Control , 2005, Brain, Behavior and Evolution.

[158]  A. Fleming,et al.  Functional Characterisation of the Maturation of the Blood-Brain Barrier in Larval Zebrafish , 2013, PloS one.

[159]  H. Würbel,et al.  Behavioral phenotyping enhanced – beyond (environmental) standardization , 2002, Genes, brain, and behavior.

[160]  J. Cachat.  Developing zebrafish models of complex phenotypes relevant to human brain disorders , 2013 .

[161]  Bryan L. Roth,et al.  Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[162]  Xiang Yang Zhang,et al.  Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[163]  Stephan C F Neuhauss,et al.  Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. , 2013, Zebrafish.

[164]  S. Kullman,et al.  Resolving mechanisms of toxicity while pursuing ecotoxicological relevance? , 2005, Marine pollution bulletin.

[165]  C. Grob,et al.  Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. , 2011, Archives of general psychiatry.

[166]  R. Poland,et al.  Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance. , 1989, The Journal of pharmacology and experimental therapeutics.

[167]  J. Arvidsson,et al.  An HRP study of the central projections of primary trigeminal neurons which innervate tooth pulps in the cat , 1981, Brain Research.

[168]  Christian Laggner,et al.  Rapid behavior—based identification of neuroactive small molecules in the zebrafish , 2009, Nature chemical biology.

[169]  I. Zhdanova,et al.  Aging of the circadian system in zebrafish and the effects of melatonin on sleep and cognitive performance , 2008, Brain Research Bulletin.

[170]  R. Griffiths,et al.  Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance , 2006, Psychopharmacology.

[171]  A. Halberstadt.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens , 2015, Behavioural Brain Research.

[172]  G. Maina,et al.  Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: a case-control study. , 2010, Journal of affective disorders.

[173]  P. Kulkarni,et al.  Oral dosing in adult zebrafish: Proof-of-concept using pharmacokinetics and pharmacological evaluation of carbamazepine , 2014, Pharmacological reports : PR.

[174]  I. Zhdanova.  Sleep and its regulation in zebrafish , 2011, Reviews in the neurosciences.

[175]  Maia J. Benner,et al.  Sex-specific transcriptional responses of the zebrafish (Danio rerio) brain selenoproteome to acute sodium selenite supplementation. , 2013, Physiological genomics.

[176]  P. Gaspar,et al.  Probing the diversity of serotonin neurons , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[177]  Franz X Vollenweider,et al.  Serotonin research: contributions to understanding psychoses. , 2008, Trends in pharmacological sciences.

[178]  Iain S. Young,et al.  What do zebrafish want? Impact of social grouping, dominance and gender on preference for enrichment , 2014, Laboratory animals.

[179]  A. Stewart,et al.  Developing zebrafish models relevant to PTSD and other trauma- and stressor-related disorders , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.